ISRCTN06135415Completed未知
Prospective, randomised, double-blinded clinical trial on remifentanil for analgesia and sedation of ventilated neonates and infants
niversity of Cologne (Germany)0 sites24 target enrollmentStarted: January 3, 2007Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 24
Study Overview
Brief Summary
2012 results in: https://www.ncbi.nlm.nih.gov/pubmed/22456770 (added 10/04/2019)
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Ventilated term newborns and infants less than 60 days
- •2. Expected time of artificial ventilation between 12 and 96 hours
Exclusion Criteria
- •1. Neuromuscular diseases
- •2. Drug abuse of the mother (exclusion criteria for newborns)
- •3. Known hypersensitivity to Ultiva® and Fentanyl-Janssen®
- •4. Missing informed consent of the parents
- •5. Participation in another clinical trial during the last four weeks before start of this trial
Investigators
Similar Trials
Completed
Phase 2
se of BETAmethasone in Ataxia TeleangectasiaHereditary ataxiaAtaxia telangiectasia (AT)Nervous System DiseasesISRCTN08774933Fondazione Monte Paschi di Siena (Italy)13
Completed
Not Applicable
Is intranasal fentanyl no worse than intravenous morphine in the treatment of painful sickle cell crisis in the paediatric emergency department?Painful sickle cell crisisHaematological DisordersSickle-cell anaemia with crisisISRCTN67469672niversity College Dublin (Ireland)31
Completed
Phase 2
stekinumab in adolescents with recent-onset type 1 diabetesNutritional, Metabolic, EndocrineType 1 diabetes mellitusISRCTN14274380Cardiff University88
Completed
Phase 3
Suppression of surgeons? skin flora during surgical procedures using a new antimicrobial surgical glovePrevention of surgical site infectionInfections and InfestationsInfection following a procedure, not elsewhere classifiedISRCTN71391952Ansell Healthcare (Belgium)52
Completed
Phase 2
The efficacy, safety and tolerability of PSD502 in subjects with premature ejaculation (PE)Premature ejaculationISRCTN57186091Plethora Solutions Ltd (UK)256